Figure 2
Meta-analysis of clinical treatment success and mortality comparing ertapenem with piperacillin/tazobactam for complicated infections treatment at test-of-cure visit. A, clinical treatment success analysis based on clinically evaluable population; B, clinical treatment success analysis based on modified intention to treat population; C, mortality analysis. Vertical line indicates no difference between ertapenem and piperacillin/tazobactam. The size of each square denotes the proportion of information given by each trial.